Jarrett Jennifer (CIK 1671311) reported 11 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-04-01). Recent activity: Buy DMRA (500,000 shares), Buy SNDX (24,000 shares), Buy RCUS (31,000 shares), Sell RCUS (11,225 shares), Sell RCUS (9,983 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-01 | Damora Therapeutics, Inc. (DMRA) | President and Chief Executive Officer | Buy | 500,000 | $0 |
| 2026-02-06 | Syndax Pharmaceuticals Inc (SNDX) | Director | Buy | 24,000 | $0 |
| 2026-01-26 | Arcus Biosciences, Inc. (RCUS) | Chief Operating Officer | Buy | 31,000 | $0 |
| 2025-12-18 | Arcus Biosciences, Inc. (RCUS) | Chief Operating Officer | Sell | 11,225 | $245,603 |
| 2025-12-18 | Arcus Biosciences, Inc. (RCUS) | Chief Operating Officer | Sell | 9,983 | $221,223 |
| 2025-11-12 | Arcus Biosciences, Inc. (RCUS) | Chief Operating Officer | Buy | 50,291 | $61,858 |
| 2025-11-12 | Arcus Biosciences, Inc. (RCUS) | Chief Operating Officer | Sell | 50,291 | $954,020 |
| 2025-10-08 | Arcus Biosciences, Inc. (RCUS) | Chief Operating Officer | Buy | 12,500 | $15,375 |
| 2025-10-08 | Arcus Biosciences, Inc. (RCUS) | Chief Operating Officer | Sell | 12,500 | $181,750 |
| 2025-10-08 | Arcus Biosciences, Inc. (RCUS) | Chief Operating Officer | Buy | 37,792 | $46,484 |
| 2025-10-08 | Arcus Biosciences, Inc. (RCUS) | Chief Operating Officer | Sell | 37,792 | $568,770 |
来源：SEC Form 4 申报文件 · 截至 2026-04-01